Corvus Gold to Trade on the Nasdaq, Obtains Full Senior US Listing Under Symbol KOR

Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, OTCQX: CORVF) https://www.commodity-tv.com/ondemand/companies/profil/corvus-gold-inc/ announces that it has received approval to up-list to the Nasdaq Capital Markets and will begin trading under the symbol “KOR” on Wednesday, August 12, 2020.  The Read More

Immunic, Inc. Announces Closing of $103.5 Million Public Offering, including Full Exercise of Underwriters‘ Option to Purchase Additional Shares

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, announced the closing of an underwritten public offering of 5,750,000 shares of its common stock at Read More

Taxing the Digital Economy: Has Corona Cancelled or Postponed the Global Tax Revolution?

The pressure was high from the outset when, with the finalisation of the BEPS Action Plan in Oct. 2015, the OECD simultaneously began to initiate a further and even more far-reaching project: an Inclusive Framework (IF) on the taxation of Read More

Jenoptik with sustained good demand from the semiconductor equipment industry and the public sector in first half-year

. – Group order intake down on prior year; order backlog slightly up – Adjusted revenue decreased by 11.9 percent to 329.0 million euros – Sharp improvement in second-quarter profitability (adjusted EBITDA margin up from 10.5% in Q1 to 15.6% Read More

Defence remains an anchor of stability during coronavirus crisis

. – The Group’s half-year sales fall by 7.7% to €2,597 million due to declining automotive markets – Coronavirus crisis causes drop in consolidated operating earnings from €163 million to €70 million – Defence continues to grow: sales rise by Read More

Interim Report First Half Year 2020

KUKA is feeling the effects of the coronavirus pandemic and the global economic crisis Customers are delaying investments and postponing planned orders Orders received, sales revenues and EBIT significantly below previous year’s level KUKA CEO Peter Mohnen: “Our focus is Read More

Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock Read More

Fraport Group Interim Report – First Half 2020: Covid-19 Pandemic Leads to Sharp Revenue and Profit Decline

Traffic volumes reach the bottom of the trough in the second quarter  Revenue slumps by nearly 50 percent during the first half of 2020  Group result (net profit) clearly negative  Liquidity secured over the long term Impacted by the Covid-19 Read More

Immunic, Inc. Announces Proposed Public Offering of 5 Million Shares of Common Stock

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that it intends to offer and sell 5 million shares of its common stock Read More